美国 · SEC FORM 4
QuidelOrtho Corp
QDEL · Nasdaq · CIK 0001906324 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
36 同一窗口内观察到的 Form 4 交易行
0 sales · 36 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-02-13 · Busky Joseph M..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 14,953,442
- 上期报告
- 14,190,525
- 日均成交量
- 1,362,233
- 回补天数
- 11.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-13 | Busky Joseph M. | 买入 (P) | Common Stock | 3,370 | USD 23.66 | USD 79,734 | SEC 申报 ↗ |
| 2026-02-13 | Strobeck Matthew | 买入 (P) | Common Stock | 10,000 | USD 23.96 | USD 239,600 | SEC 申报 ↗ |
| 2026-02-13 | Busky Joseph M. | 买入 (P) | Common Stock | 3,370 | USD 23.66 | USD 79,734 | SEC 申报 ↗ |
| 2026-02-13 | Blaser Brian J. | 买入 (P) | Common Stock | 10,540 | USD 23.59 | USD 248,639 | SEC 申报 ↗ |
| 2025-12-10 | RHOADS ANN D | 买入 (P) | Common Stock | 750 | USD 28.28 | USD 21,210 | SEC 申报 ↗ |
| 2025-11-26 | Wilkins Joseph D Jr. | 买入 (P) | Common Stock | 370 | USD 27.96 | USD 10,345 | SEC 申报 ↗ |
| 2025-11-24 | Busky Joseph M. | 买入 (P) | Common Stock | 4,770 | USD 26.06 | USD 124,306 | SEC 申报 ↗ |
| 2025-11-21 | POLAN MARY LAKE PH D | 买入 (P) | Common Stock | 1,000 | USD 22.43 | USD 22,430 | SEC 申报 ↗ |
| 2025-11-19 | Blaser Brian J. | 买入 (P) | Common Stock | 23,500 | USD 21.34 | USD 501,490 | SEC 申报 ↗ |
| 2024-12-11 | Blaser Brian J. | 买入 (P) | Common Stock | 6,033 | USD 41.42 | USD 249,887 | SEC 申报 ↗ |
| 2024-02-23 | Busky Joseph M | 买入 (P) | Common Stock | 2,150 | USD 46.36 | USD 99,674 | SEC 申报 ↗ |
Form 4 申报证据
79 transaction lines in the latest 365-day window; 474 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Bowman Ronald Lee | 期权行权/转换 (M) | Common Stock | 2,566 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-15 | Bowman Ronald Lee | 代扣税 (F) | Common Stock | 921 | USD 10.63 | USD 9,790 | SEC 申报 ↗ |
| 2026-08-15 | Hanson Bryan Michael | 期权行权/转换 (M) | Common Stock | 446 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Bowman Ronald Lee | 期权行权/转换 (M) | Common Stock | 2,566 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-15 | Bowman Ronald Lee | 代扣税 (F) | Common Stock | 921 | USD 10.63 | USD 9,790 | SEC 申报 ↗ |
| 2026-08-15 | Hanson Bryan Michael | 期权行权/转换 (M) | Common Stock | 446 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-15 | Hanson Bryan Michael | 代扣税 (F) | Common Stock | 162 | USD 14.30 | USD 2,317 | SEC 申报 ↗ |
| 2026-07-01 | Hanson Bryan Michael | 期权行权/转换 (M) | Common Stock | 5,797 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Hanson Bryan Michael | 代扣税 (F) | Common Stock | 2,096 | USD 18.18 | USD 38,105 | SEC 申报 ↗ |
| 2026-06-06 | WIDDER KENNETH J | 奖励/授予 (A) | Common Stock | 1,183 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-06 | POLAN MARY LAKE PH D | 奖励/授予 (A) | Common Stock | 973 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-06 | Michael Edward L. | 奖励/授予 (A) | Common Stock | 1,252 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-06 | BUECHLER KENNETH F | 奖励/授予 (A) | Common Stock | 2,156 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Wilkins Joseph D Jr. | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | WIDDER KENNETH J | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Strobeck Matthew | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | RHOADS ANN D | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | POLAN MARY LAKE PH D | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Michael Edward L. | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Huennekens R Scott | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Dilsaver Evelyn S | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | Chiminski John R | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-29 | BUECHLER KENNETH F | 奖励/授予 (A) | Common Stock | 6,829 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-22 | RHOADS ANN D | 奖励/授予 (A) | Common Stock | 1,407 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Blaser Brian J. | 代扣税 (F) | Common Stock | 10,252 | USD 10.32 | USD 105,801 | SEC 申报 ↗ |
| 2026-05-15 | Blaser Brian J. | 奖励/授予 (A) | Common Stock | 20,759 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-26 | McLellan Philip D. | 代扣税 (F) | Common Stock | 699 | USD 11.59 | USD 8,101 | SEC 申报 ↗ |
| 2026-04-26 | McLellan Philip D. | 奖励/授予 (A) | Common Stock | 1,946 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-26 | Hanson Bryan Michael | 代扣税 (F) | Common Stock | 528 | USD 11.59 | USD 6,120 | SEC 申报 ↗ |
| 2026-04-26 | Hanson Bryan Michael | 奖励/授予 (A) | Common Stock | 1,459 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-22 | McLellan Philip D. | 代扣税 (F) | Common Stock | 1,162 | USD 11.90 | USD 13,828 | SEC 申报 ↗ |
| 2026-04-22 | McLellan Philip D. | 奖励/授予 (A) | Common Stock | 3,238 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-22 | Hanson Bryan Michael | 代扣税 (F) | Common Stock | 1,269 | USD 11.90 | USD 15,101 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | QDEL |
| CIK | 0001906324 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 2835 In Vitro & In Vivo Diagnostic Substances |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 474 transaction lines from 2020-08-28 to 2026-09-15 11 P purchase lines · 106 S sale lines · 357 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.